EN DE

Indo Borax & Chemicals Limited (INDOBORAX) Fair Value & Analysis

Basic Materials · IN · Market cap ₹12.6B

IB Indo Borax & Chemicals Limited INDOBORAX · NSE
Price₹425.35
Fair Value₹182.77
Upside-57.0%
Quality72/100
Watch Indo Borax & Chemicals Limited for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Highly profitable · 23.3% net margin
generates free cash flow
2.66% dividend yield
Ranks above peers (8/13)
Wide moat 70/100
Evidence: High Range ₹138.05 – ₹254.26 Share as image

Fair value as of: Aug 13, 2026

From 26 valuation models · updated 3 days ago

Share price +2.9% over the past month.

A solid business, but screening 57% overvalued on our models.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • A high-quality business (quality 72/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The price sits above even our optimistic bull case (₹254.26). The favourable scenario is already priced in.
  • A fairly wide model range (₹138.05 to ₹254.26) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (4 years)

₹449.05 ₹86.83 Fair Value ₹182.77 Mar 2022 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

53‑month range ₹86.83 – ₹449.05 · fair‑value band ₹138.05 – ₹254.26 · the ₹425.35 price screens above the ₹182.77 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Indo Borax & Chemicals Limited (INDOBORAX) currently trades at ₹425.35, while our model-based Fair Value estimate is ₹182.77, implying the stock looks roughly 57.0% overvalued today. The Quality Score stands at 72/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Indo Borax & Chemicals Limited generated revenue of ₹2.2B at a net margin of 23.3%. Revenue grew 20.4% year over year. It earns a return on equity of 13.9%. The balance sheet holds a net cash position of ₹125M. Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹138.05 (bear case) to ₹254.26 (bull case); at ₹425.35, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 100% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -60% fair-value upside, at -57%, INDOBORAX screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income ₹114.29 ₹143.88 ₹382.12 76
Growth DCF ₹394.24 ₹704.86 ₹1,242 72
Gordon GGM ₹9.18 ₹19.09 ₹30.29 70
All 26 models by family
DCF Models
FCF DCF ₹399.37 ₹744.47 ₹1,363 38
Owner Earnings ₹224.16 ₹416.19 ₹760.13 31
5Y Revenue Exit ₹176.75 ₹255.25 ₹353.02 39
5Y EBITDA Exit ₹194.40 ₹292.42 ₹409.39 41
5Y P/E Exit ₹255.96 ₹422.09 ₹611.36 38
10Y Revenue Exit ₹244.91 ₹346.35 ₹487.84 36
10Y EBITDA Exit ₹259.19 ₹373.93 ₹536.03 37
10Y P/E Exit ₹300.38 ₹470.12 ₹708.69 35
Earnings-Based
Graham-Dodd ₹106.52 ₹531.20 ₹732.94 54
Lynch FV ₹143.54 ₹205.06 ₹266.58 50
PEG = 1.0 ₹143.54 ₹205.06 ₹266.58 46
EPV ₹77.79 ₹90.04 ₹100.75 59
Dividend Discount
Gordon GGM ₹9.18 ₹19.09 ₹30.29 70
DDM Multi-Stage ₹9.18 ₹16.10 ₹20.04 61
Multiples
P/E Multiple ₹199.73 ₹266.31 ₹332.89 63
P/S Multiple ₹75.53 ₹100.71 ₹125.89 58
P/B Multiple ₹199.73 ₹266.31 ₹332.89 55
EV/EBIT ₹138.49 ₹183.21 ₹227.93 53
EV/EBITDA ₹107.54 ₹141.94 ₹176.34 54
EV/Revenue ₹74.83 ₹105.04 ₹135.25 43
Asset-Based
NCAV (Graham) ₹60.23 ₹80.71 ₹120.47 50
Growth DCF
Growth DCF ₹394.24 ₹704.86 ₹1,242 72
Rev-Margin DCF ₹176.75 ₹258.35 ₹366.80 67
Economic Profit
Residual Income ₹114.29 ₹143.88 ₹382.12 76
ROIC Compounder ₹77.79 ₹90.04 ₹100.75 67
Growth Earnings
Growth-Adj P/E ₹197.44 ₹282.05 ₹366.67 68

Widest divergence: DCF Models (₹373.93) versus Dividend Discount (₹16.10). Highest evidence: Residual Income (76).

Notify me when INDOBORAX reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹2.2B
Revenue growth (YoY) +20.4%
Net margin 23.3%
Return on equity 13.9%
Free cash flow ₹955M FY2026
P/E ratio 27.2
More key figures
Operating margin 19.3%
EPS (TTM) ₹15.66
Dividend yield 2.7%
EPS growth (YoY) +42.0%
Net cash ₹125M FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 72/100

Of which business quality 72 · Market factors (momentum, volatility) 84

Profitability 58
Margins and returns on capital today
Quality Growth 44
Are margins and returns improving?
Cashflow 98
Earnings quality: real cash, not paper profit
Fin. Strength 82
Balance sheet, leverage, solvency risk
Investment 52
Disciplined investing over empire-building
Low Volatility 45
Calm price path (market factor)
Momentum 100
Price trend over the last 3–12 months (market factor)
52W Momentum 100
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Indo Borax & Chemicals Limited manufactures and sells boron and lithium products in India. It offers borax products, such as decahydrate crystals and granular; boric acid products that include boric acid Indian pharmacopoeia grade, and technical grade granular, and powders; lithium hydroxide monohydrate products; boron oxide; and disodium octaborate …

Full company description

Indo Borax & Chemicals Limited manufactures and sells boron and lithium products in India. It offers borax products, such as decahydrate crystals and granular; boric acid products that include boric acid Indian pharmacopoeia grade, and technical grade granular, and powders; lithium hydroxide monohydrate products; boron oxide; and disodium octaborate tetrahydrate. The company was incorporated in 1980 and is based in Mumbai, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Indo Borax & Chemicals Limited reported revenue of ₹2.2B in FY2026 versus ₹1.8B in FY2022, a compound +5.2%/yr. Reported net income was ₹503M in FY2026, compounding +8.4%/yr from FY2022.

Growth Quality 87/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2026)
₹2.2B
Latest YoY
+22.9%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.4%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.4%
Avg. growth/yr (20Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+12.6%
Revenue +5.2%/yr
FY22 ₹1.8B
FY23 ₹2.3B
FY24 ₹1.9B
FY25 ₹1.8B
FY26 ₹2.2B
Net income +8.4%/yr
FY22 ₹364M
FY23 ₹507M
FY24 ₹390M
FY25 ₹425M
FY26 ₹503M
Character of growth · EPS growth decomposed (2015-2026) +17.8 % p.a.
Revenue per share +11.2 pp

of which total revenue +11.2 pp · buybacks/dilution +0.0 pp

EBIT margin +1.6 pp
Tax rate +1.0 pp
Residual (interest, one-offs) +4.0 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

INDOBORAX screens 57% overvalued. Compare with BASF SE →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Indo Borax & Chemicals Limited Fair Value". https://www.fairvalue-calculator.com/stock/INDOBORAX

Peer Group

Chemicals · 331 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 72 · Top 25%
Fair Value upside −57% · Below median
Return on equity (TTM) 14% · Top 25%
Return on assets 7% · Top 25%
Net margin (TTM) 23% · Top 25%
Operating margin (TTM) 19% · Top 25%
Revenue growth 20% · Top 25%
Dividend yield (TTM) 2.7% · Above median

Valuation Multiples vs Chemicals median · lower = cheaper

P/E (TTM) 27.2× · Pricier than median
P/B 3.25× · Pricier than 75% of peers
P/S (TTM) 5.83× · Pricier than 75% of peers
P/FCF 0.1× · Cheaper than 75% of peers
EV/EBITDA 28.1× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 100 · sector 20
PAST 56 · sector 20
HEALTH 0 · sector 94
DIVIDEND 53 · sector 33

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
BASF SE BASN 1,034 MXN 467.04 MXN -55%
PT Barito Pacific Tbk, BRPT 1,950 IDR 1,608 IDR -18%
LG Chem, Ltd 051910 275,500 KRW 587,755 KRW +113%
SRF Limited 503806 ₹2,609 ₹749.17 -71%
542812 542812 ₹4,709 ₹791.05 -83%
Navin Fluorine International Limited NAVINFLUOR ₹8,357 ₹2,146 -74%
506285 506285 ₹4,048 ₹1,589 -61%
Kansai Nerolac Paints Limited 500165 ₹209.25 ₹80.51 -62%
Deepak Nitrite Limited DEEPAKNTR ₹1,718 ₹679.17 -60%
KCC Corporation 002380 454,000 KRW 1,763,304 KRW +288%

Compare Indo Borax & Chemicals Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Indo Borax & Chemicals Limited (INDOBORAX) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of ₹182.77 versus a price of ₹425.35, about −57% (overvalued).
What is the fair value of INDOBORAX?
Our model-based fair value for Indo Borax & Chemicals Limited is ₹182.77 (as of Aug 13, 2026), built from audited fundamentals. The current price is ₹425.35.
What is the quality score of INDOBORAX?
Indo Borax & Chemicals Limited has a Quality Score of 72/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Indo Borax & Chemicals Limited (INDOBORAX)?
Indo Borax & Chemicals Limited reported trailing-twelve-month revenue of about ₹2.2B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of INDOBORAX?
The net profit margin of Indo Borax & Chemicals Limited is about 23.3%, meaning it keeps roughly 23.3% of revenue as net income. Based on the latest reported figures.
Does Indo Borax & Chemicals Limited pay a dividend?
Indo Borax & Chemicals Limited currently shows a dividend yield of about 2.66% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Indo Borax & Chemicals Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.